FDA - Food and Drug Administration

Cellular Intelligence strikes deal with Novo Nordisk to advance Parkinson’s cell therapy

'This cell therapy Parkinson's program is truly innovative and exemplifies the powerful convergence of exciting academic discovery with the uncompromising quality of a global pharmaceutical leader.'

In this photo illustration, a smartphone displays the logo of Novo Nordisk (NYSE: NVO), a Denmark-based pharmaceutical company specializing in diabetes care, obesity treatment, in front of a screen showing the company's latest stock market chart, January 29, 2026
US HEALTH and Human Services Secretary Robert F. Kennedy Jr.

RFK Jr.’s health department ordered withdrawal of studies showing vaccine efficiency - report

A person cups their hand to their ear in an act of listening (illustrative)

'Miracle cure': 2-year-old steals show at White House announcement of hearing loss therapy approval

 U.S. President Donald Trump signs an executive order encouraging more research into ibogaine, next to U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy Jr., Joe Rogan, and Americans for Ibogaine CEO W. Bryan Hubbard, in the Oval Office of the White House in Washington, D.C., April 18

Trump signs order to accelerate Ibogaine research for veterans with PTSD 


Israeli pride: Phytolon receives FDA approval – sparks significant interest in the U.S.

Millennium FoodTech R&D Partnership: Portfolio company Phytollon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S.

Portfolio company Phytoon, which develops natural and innovative food colorings, received FDA approval to market its first product in the U.S

FDA clears AI model to triage urgent CT findings, Israeli firm says

Aidoc won FDA clearance for a 'foundation model' clinical AI that triages 14 abdomen-CT indications in one workflow, aiming to surface urgent findings faster amid ED crowding and imaging backlogs.

(Illustrative) A doctor uses AI for a medical screening.

FDA clears first US trial of Israel’s EndoArt synthetic corneal implant

EyeYon Medical says FDA granted IDE for a multicenter study led by Scripps Clinic’s Prof. Francis Mah, with enrollment targeted to begin in March 2026.

ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.

Arizona couple admits in court to faking cancer-curing 'smart chip' device

At clinics in Arizona and several other states, Mary Blakley and her husband told patients that, for just $300, they could provide a full-body scan to detect a variety of potential illnesses.

 Dividing cancer cell

Forget the injections: The FDA has approved a daily weight-loss pill for the first time

A daily pill version of the weight-loss drug Wegovy shows significant weight reduction, greater convenience, and hope for making treatment accessible to millions of patients.

Wegovy pills

Weight-loss pill approval set to accelerate food industry product overhauls

As GLP-1 pills become widely available, food companies and restaurants are adjusting to rising demand for high-protein, smaller portions to meet weight-loss trends.

Semaglutide pills; illustrative.

Kennedy seeks to cut US children's access to gender-affirming care

Kennedy proposed rules barring hospitals that provide such care from participating in Medicare and Medicaid programs and prohibiting Medicaid from paying for it.

US Secretary of Health and Human Services Robert F. Kennedy Jr. speaks with US Vice President JD Vance (not pictured) during the inaugural Make America Healthy Again (MAHA) summit in Washington, DC, US, November 12, 2025.

Israeli firm receives FDA approval to begin clinical trial of chronic corneal edema treatment

The company describes EndoArt as the world’s first synthetic endothelial layer for the treatment of chronic corneal edema.

ENDOART, A synthetic endothelial layer for the treatment of chronic corneal edema.

Children born with deadly immune flaw get powerful new gene therapy option

Gene therapy uses the patient's own blood stem cells, which were genetically modified to include functional copies of the WAS gene, the FDA said.

 Gene therapy restores hearing in children and adults with congenital deafness. Illustration.

US FDA memo links 10 child deaths to COVID vaccines, New York Times reports

The findings of the new FDA review have not been published in a peer-reviewed medical journal, the NYT reported. Additionally, the memo did not disclose the ages or health conditions of the children.

 A woman is seen preparing a dose of the COVID vaccine.